Trial
NCT02372578
Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects With Painful Diabetic Peripheral Neuropathy
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Astellas Pharma Global Development, Inc.
Collaborators
—
Condition
Painful Diabetic Peripheral Neuropathy (PDPN)
Intervention
ASP3662
Why stopped
The study was terminated due to futility analysis.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-03-26